Dergiler / Turkish Journal of Veterinary and Animal Sciences / 2018 / Cilt: 42 - Sayı: 5

Assessment of tumor-induced pain and C-reactive protein levels in dogs with canine transmissible venereal tumors

Sayfa
429–434
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

However, hematology profiles and serum CRP levels are independent of the localized tumor proliferation.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The aim of this study was to determine the impact of tumor volume on generalized behavior, pain perception, and serumC-reactive protein (CRP) in dogs with canine transmissible venereal tumors (CTVTs).
📊
Temel Bulgular & Veri:Molecular identification of CTVTs was carried out using PCR assays based on LINE-1/c-myc.
💡
Sonuç & Katkı:However, hematology profiles and serum CRP levels are independent of the localized tumor proliferation.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

The aim of this study was to determine the impact of tumor volume on generalized behavior, pain perception, and serumC-reactive protein (CRP) in dogs with canine transmissible venereal tumors (CTVTs). Pain scoring was performed using theGlasgow Composite Measure Pain Scale Short-Form. Cytomorphology of the tumors was studied through fine-needle aspiration andhistopathology. Molecular identification of CTVTs was carried out using PCR assays based on LINE-1/c-myc. Hematological profilesincluding complete blood count and CRP were analyzed using an automatic hematology analyzer and immunoturbidimetric assays,respectively. Chi-square and regression analysis statistics were used for data analysis. Results of the study revealed a statisticallysignificant (R2 = 0.798) impact of tumor volume on pain scores in corresponding individuals. Hematological parameters and serumCRP values were observed in normal ranges and did not reveal any significant association with tumor volume. All of the samples werefound positive for LINE-1/c-myc molecular rearrangement, revealing a 552-bp PCR product. On the basis of cytology tumors weredifferentiated into plasmacytoid, lymphocytoid, and mixed types. No significant association could be observed among cytological typesand sex of the individuals. It may be concluded that increasing tumor size may result in localized pain and mild behavioral alterations inaffected dogs. However, hematology profiles and serum CRP levels are independent of the localized tumor proliferation.

🔖

Bu Makaleye Atıf Yap

ANJUM, A. A., AZEEM, M., KHAN, M., SALEEM, G., AHMAD, W., ZIA, U., AKRAM, F. (2022). Assessment of tumor-induced pain and C-reactive protein levels in dogs with canine transmissible venereal tumors. Turkish Journal of Veterinary and Animal Sciences, Cilt: 42 - Sayı: 5, 429–434. https://ajindex.com/articles/614985

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Setthawongsin C, Techangamsuwan S, Tangkawattana S, Rungsipipat A. Cell-based polymerase chain reaction for canine transmissible venereal tumor (CTVT) diagnosis. J Vet Med Sci 2016; 78: 1167-1173
  2. Pye RJ, Pemberton D, Tovar C, Tubio JM, Dun KA, Fox S, Darby J, Hayes D, Knowles GW, Kreiss A. A second transmissible cancer in Tasmanian devils. P Natl Acad Sci USA 2016; 113: 374-379
  3. Ganguly B, Das U, Das AK. Canine transmissible venereal tumour: a review. Veterinary comp oncol 2016; 14: 1-12
  4. Das U, Das AK. Review of canine transmissible venereal sarcoma. Vet Res Comm 2000; 24: 545-556
  5. Javanbakht J, Pedram B, Taheriyan M, Khadivar F, Hosseini S, Abdi F, Hosseini E, Moloudizargari M, Aghajanshakeri SH, Javaherypour S. Canine transmissible venereal tumor and seminoma: a cytohistopathology and chemotherapy study of tumors in the growth phase and during regression after chemotherapy. Tumor Biol 2014; 35: 5493-5500
  6. Chun JM, Kwon HJ, Sohn J, Kim SG, Park JY, Bae HI, Yun YK, Hwang YJ. Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma. J Surg Oncol 2011; 103: 148-151
  7. Gakis G, Todenhöfer T, Renninger M, Schilling D, Sievert KD, Schwentner C, Stenzl A. Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C‐reactive protein and standard pathological risk factors: the TNR‐C score. BJU Int 2011; 108: 1800-1805
  8. Nozoe T, Saeki H, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg 2001; 182: 197- 201
  9. McMillan D, Canna K, McArdle C. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 2003; 90: 215-219
  10. Ueno H, Okada S, Okusaka T, Ikeda M. Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy. Oncology 2000; 59: 296-301
  11. Scott H, McMillan D, Forrest L, Brown D, McArdle C, Milroy R. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 2002; 87: 264-267
  12. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, Baumgartner KB, Gilliland FD, Sorensen BE, McTiernan A. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 2009; 27: 3437-3444.